Correlation Between Mineralys Therapeutics, and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and C4 Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and C4 Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and C4 Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Mineralys and CCCC is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and C4 Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.01 times more return on investment than C4 Therapeutics. However, Mineralys Therapeutics, is 1.01 times more volatile than C4 Therapeutics. It trades about -0.05 of its potential returns per unit of risk. C4 Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 1,389 in Mineralys Therapeutics, Common on August 27, 2024 and sell it today you would lose (119.00) from holding Mineralys Therapeutics, Common or give up 8.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. C4 Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| C4 Therapeutics |
Mineralys Therapeutics, and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and C4 Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |